Astrazeneca Pharma India (ASTRAZEN) Share Price hits fresh 52-week low at Rs 5,660
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
Astrazeneca Pharma India Share Price touched a fresh 52-week low of Rs 5,660 and now trades at Rs 5,710, up 0.10% today. Market capitalisation stands at Rs 14,260.13 Cr as of 09 October 2026 at 10:22 AM IST.
Astrazeneca Pharma India Share Price is in focus after the stock touched a fresh 52-week low of Rs 5,660 and last traded at Rs 5,710, up Rs 5.95 or 0.10% from the previous close of Rs 5,704.05. The price move is confirmed in Univest data; a company-specific reason has not been established. The market capitalisation is Rs 14,260.13 Cr, placing Astrazeneca Pharma India Share Price in a large-cap-style market value bracket without using any separate label here. For readers following Astrazeneca Pharma India Share Price today, the move matters because it sets a one-year low reference point while the stock remains above that level at the time of writing.
According to latest Univest figures, Astrazeneca Pharma India Share Price moved between Rs 5,660 and Rs 5,726 during the day, with the open and high both at Rs 5,726. That range keeps the fresh low visible in the price record even as the quote sits above it. Astrazeneca Pharma India Stock News is therefore centered on a verified low-print event, current valuation and sector comparison rather than on any unverified trigger. The next sections place Astrazeneca Pharma India Share Price in context through fundamentals, healthcare industry benchmarks and peer data.
Astrazeneca Pharma India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,710 |
| Previous Close | Rs 5,704.05 |
| Today's Move | +Rs 5.95 (+0.1%) |
| Open | Rs 5,726 |
| High | Rs 5,726 |
| Low | Rs 5,660 |
| Market Capitalisation | Rs 14,260.13 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 5,710 versus the previous close of Rs 5,704.05, a rise of 0.1%. The stock opened at Rs 5,726, reached a high of Rs 5,726, touched a low of Rs 5,660.
Astrazeneca Pharma India Share Price today shows a narrow net gain versus the previous close, but the day still produced a fresh 52-week low at Rs 5,660. The stock opened at Rs 5,726, touched the same Rs 5,726 high, and printed Rs 5,660 as the low before last trading at Rs 5,710. That means Astrazeneca Pharma India Share Price is trading only slightly above the fresh yearly low, with the current quote Rs 5.95 higher than the previous close. For anyone tracking Astrazeneca Pharma India Share Price live, the key price markers are the previous close, the day range and the one-year low.
Astrazeneca Pharma India Share Price also matters for traders and long-term readers because the market cap of Rs 14,260.13 Cr gives the move a large balance-sheet footprint in absolute market value terms. The verified price action does not establish a company-specific reason, so Astrazeneca Pharma India Share Price news remains anchored to the observable low and the small positive day change. The next lens is Astrazeneca Pharma India Fundamental Analysis, where valuation and return ratios add context to the stock’s standing.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 14,260.13 crore |
| P/E Ratio | 84.07x |
| P/B Ratio | 15.77x |
| ROE | 23.02% |
| ROCE | 31.24% |
| EPS | Rs 67.85 |
| Book Value Per Share | Rs 361.68 |
| Dividend Yield | 0.63% |
Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P/E 84.07x, P/B 15.77x, ROE 23.02%, ROCE 31.24%. These ratios show where the company stands today and are not a call to buy or sell.
Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 14,260.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.07x, P/B at 15.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.63%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.27x, median ROE of 11.53%, median ROCE of 13.32%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 84.07x |
| Benchmark Median P/E | 31.27x |
| Benchmark Average P/E | 46.87x |
| Benchmark P/E Range | 3.56x to 678.22x |
| Company P/B Ratio | 15.77x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 23.02% |
| Benchmark Median ROE | 11.53% |
| Company ROCE | 31.24% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 14,260.13 crore |
| Benchmark Median Market Cap | Rs 803.77 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 84.07x, which is above the benchmark median of 31.27x, a difference of +168.85%. A P/E difference of this kind is a reference point rather than a recommendation.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.53%, a difference of +99.65%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.32%, a difference of +134.53%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Concord Biotech Ltd. | CONCORDBIO | 14,198.51 | 50.53 | 6.71 | 13.54 | 18.04 |
| Marksans Pharma Ltd. | MARKSANS | 14,741.42 | 27 | 4.39 | 15.31 | 21.1 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 13,179.41 | 68.76 | 13.59 | 25.37 | 28.5 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 15,517.96 | 42.17 | 2.08 | 5.97 | 8.69 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | 12,939.36 | 42.4 | 3.62 | 8.06 | 14.77 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 84.07x compared with the displayed peer median of 42.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 13.54% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 18.04%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 14,260.13 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India
- Astrazeneca Pharma India Share Price touched a fresh 52-week low of Rs 5,660 and last traded at Rs 5,710.
- The day range for Astrazeneca Pharma India Share Price was Rs 5,660 to Rs 5,726, with the previous close at Rs 5,704.05.
- Astrazeneca Pharma India Share Price carries a high P/E of 84.07 and P/B of 15.77 versus industry medians below those levels.
- ROE of 23.02% and ROCE of 31.24% keep Astrazeneca Pharma India Share Price in focus for fundamental analysis.
- Market capitalisation of Rs 14,260.13 Cr places Astrazeneca Pharma India Share Price near several listed pharma peers by size.
About Astrazeneca Pharma India
Astrazeneca Pharma India Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Astrazeneca Pharma India Share Price reflects a business that is tracked in the listed pharmaceutical space, where earnings quality, return ratios and valuation are usually read together.
For Astrazeneca Pharma India Share Price readers, the key business points available here are the sector, industry, market capitalisation and the latest quarterly revenue figure of Rs 682.79 Cr for Jun 2026. That revenue number gives a recent operating reference point, while the dividend yield of 0.63% and book value of Rs 361.68 add balance-sheet and payout context. Astrazeneca Pharma India Stock News today is therefore best understood as a mix of pricing, valuation and healthcare-industry comparison.
Track Astrazeneca Pharma India Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Track Astrazeneca Pharma India Share Price on Univest for live quote updates, market cap, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield and 52-week levels. Astrazeneca Pharma India Share Price live tracking on Univest also helps readers follow Stock News, Stock Analysis and Stock Performance in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Astrazeneca Pharma India Share Price today?
Ans. Astrazeneca Pharma India Share Price is Rs 5,710 as of 09 October 2026 at 10:22 AM IST. It is up Rs 5.95, or 0.10%, from the previous close of Rs 5,704.05.
What is the fresh 52-week low for Astrazeneca Pharma India Share Price?
Ans. Astrazeneca Pharma India Share Price touched a fresh 52-week low of Rs 5,660. The stock later traded at Rs 5,710, so the current quote remains above that yearly low. The stock moved 0.1% during the session.
Why is Astrazeneca Pharma India Share Price in news today?
Ans. Astrazeneca Pharma India Share Price is in news because it touched a fresh 52-week low while also showing a small gain versus the previous close. According to Univest data, no company-specific catalyst is established.
What is the market capitalisation of Astrazeneca Pharma India?
Ans. Astrazeneca Pharma India Share Price is associated with a market capitalisation of Rs 14,260.13 Cr. That places the company well above the industry median market cap shown in the sector snapshot.
How does Astrazeneca Pharma India Share Price compare on valuation?
Ans. Astrazeneca Pharma India Share Price carries a P/E of 84.07 and a P/B of 15.77. Both are above the healthcare industry medians of 31.27 and 2.83 in the Univest benchmark set.
What do ROE and ROCE show for Astrazeneca Pharma India Share Price?
Ans. Astrazeneca Pharma India Share Price shows ROE of 23.02% and ROCE of 31.24%. Those figures are stronger than the sector medians of 11.53% for ROE and 13.32% for ROCE. The stock moved 0.1% during the session.
What is the EPS and book value for Astrazeneca Pharma India?
Ans. Astrazeneca Pharma India Share Price has EPS of Rs 67.85 and book value of Rs 361.68. EPS measures earnings per share, while book value shows the accounting net worth behind each share.
Does Astrazeneca Pharma India Share Price offer a dividend yield?
Ans. Astrazeneca Pharma India Share Price has a dividend yield of 0.63%. That is a historical payout measure, so it should be read alongside valuation, revenue and return ratios rather than in isolation.
Which peers are useful for Astrazeneca Pharma India Share Price comparison?
Ans. Astrazeneca Pharma India Share Price can be compared with Concord Biotech, Marksans Pharma, Sudeep Pharma, Jubilant Pharmova and Akums Drugs & Pharmaceuticals. Their market cap and valuation ratios provide a practical peer set.
